Cepeginterferon alfa-2b

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCepeginterferon alfa-2b
Drug Alias Name西培干扰素α-2bCepeginterferon alpha-2bcepeginterferonum alfa-2b塞培干扰素α-2bCepeginterferon α-2b +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsImmunologic Deficiency SyndromesHepatitisHepatitis C
Global Approved IndicationsHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2013/12/01
Country/TerritoryThailandRussian FederationBelarus +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBIOCAD JSC
China Registration ClassN/A

Develop Information

Active CompaniesBIOCAD JSC
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsImmunologic Deficiency SyndromesHepatitis

Other Information

ATC CodeL03AB14
Related LinksN/A